$5.1MSeries A, 26 November 2025
Funds scale the platform to GMP industrial production of QS-21 and related saponins.
- Amount
- $5.1M
- Stage
- Series A
- Announced
- 26 November 2025
- Lead
- GO Capital
- Other investors
- Critical Path Ventures
- Use of funds
- Funds scale the platform to GMP industrial production of QS-21 and related saponins.
- Checked
- Amount and date checked against the press source
- Source
- Alkion BioInnovations raises 4.4 million euros to industrialise sustainable adjuvant production gazettelabo.fr